Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala at the University of Eastern Finland, with Professor Seppo Vainio from the University of Oulu as its deputy director. Other partners in the Flagship include the University of Helsinki, Aalto University and the Finnish Red Cross Blood Service.
The Academy of Finland completed the flagship program – Biocenter Oulu group leaders participate in the GeneCellNano project
The GeneCellNano (Gene, Cell and Nano Therapy Competence Cluster for the Treatment of Chronic Diseases) project is led by Academy Professor Seppo Ylä-Herttuala and the Deputy Dire
Academy of Finland supplemented its flagship programme — University of Oulu included in the GeneCellNano project
Four new competence clusters have been added to the Academy of Finland’s Flagship Programme. The University of Oulu is involved in the GeneCellNano Flagship, i.e. Gene, Cell and Nano Therapy Competence Cluster for the Treatment of Chronic Diseases.
BCO group leaders professors Risto Kerkelä and Juhani Junttila have received Academy of Finland 4-year project funding 1.9.2020-31.8.2024 for their projects “Molecular mechanisms of cardiac ageing,
Professor Caglar Elbuken arrived in Oulu last winter from Ankara, Turkey, to take on a new career challenge. Namely, the founding of two research groups for the University of Oulu and the VTT Technical Research Center of Finland, respectively.
From today, the Finnish Infrastructure for Integrative Structural Biology will open its doors to European scientists as Instruct Centre FI.
More information here.
Academy of Finland FIRI funding and a grant from the Erkko Foundation to develop Biocenter Oulu Core facilities
Biocenter Oulu Protein crystallography core facility, a member of
Jane and Aatos Erkko Foundation has granted significant funding to the researchers of the University of Oulu. Foundation has granted 1,5 million euro funding for Professors Johanna Myllyharju and Peppi Karppinen of the University of Oulu. The grant was awarded for hypoxia-related research (Key enzyme regulators of the hypoxia response, collagen synthesis and epigenetic pathways as therapeutic targets) for five years.
The Biocenter Oulu Discovery of the Year 2019 Event was held on December 17. Here are the winners announced in the event:
Biocenter Oulu, a node site of Euro-BioImaging ERIC, receives Academy of Finland FIRI funding (total 1 000 000 €) to advance microscope imaging technologies designed for visualization of microscopi
Rector Jouko Niinimäki has on December 9, 2019 appointed Professor Johannes Kettunen as the new Director of Focus institute Biocenter Oulu. The position is for 4 years and starts on 1.1.2020.
This year’s Nobel Prize in Medicine will be awarded on 10 December to three researchers studying hypoxia – low oxygen concentrations. The Faculty of Biochemistry and Molecular Medicine of the University of Oulu has made its significant contribution to the subject.
From the Academy of Finland Molecular Regulatory Networks of Life (R´Life) Funding, the Consortium ELMI: (The leukemic matrisome interface as a source of markers and targets for acute myeloid leuke
The European Commission has officially established Euro-BioImaging – which provides life scientists with open access to a broad range of technologies an
The start-up company FinnAdvance, resulting from vascular and lymphatic research at the University of Oulu, has won the Tech Start-up Award 2019, a large international innovation competition in Cologne.
BCO group leaders Profs. Koivunen and Myllyharju have on-going collaboration with Nobel Prize winners
The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L.
Professor Gong-Hong Wei’s research group awarded for their work into the mechanisms of aggressive prostate cancer
The Minerva Foundation’s Medix prize in biomedical basic research has this year been awarded to a research group headed by Professor of Biochemistry and Molecular Medicine Gong-Hong Wei at the University of Oulu.
Body mass index (BMI) in infants, children and adults is influenced by different genetic factors that change as we age, according to a major new study.
Researchers of the University of Oulu have participated in a study that identified a combination of blood-based biomarkers that were associated with life expectancy consistently across five European countries.
Rector's decision: Appointment of research projects to Biocenter Oulu Institute for a period of 2020 - 2023
The call for new Biocenter Oulu research projects for 2020 – 2023 was published in October 11th, 2018. The call was closed in January 14th, 2019.
Meet the Top Scientist seminar was held on Tellus Stage on the 7th of May. There were presentations by three scientists, prof. Juha Röning, Prof. Johanna Uusimaa and Dr.
Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction. The researchers employed gene manipulation technology to remove the P4h-tm gene from the mouse genome and found an unexpected change in mouse behaviour. P4h-tm knockout mice showed striking courage and a lack of learned helplessness compared to congenic wild-type mice with a functional P4h-tm gene. The results were published in Neuropharmacology.
Researchers found a new mechanism with which cells can sense oxygen: new opportunities will open for the development of cancer drugs